Ülke: Avustralya
Dil: İngilizce
Kaynak: Department of Health (Therapeutic Goods Administration)
Alfuzosin hydrochloride
Sanofi-Aventis Australia Pty Ltd
Medicine Registered
PRODUCT INFORMATION May 2013 Xatral and Xatral ER - alfuzosin hydrochloride xatral-xatral-er-ccdsv10-piv8-28may13 Page 1 PRODUCT INFORMATION XATRAL ® AND XATRAL ® ER NAME OF MEDICINE AUSTRALIAN APPROVED NAME Alfuzosin hydrochloride CHEMICAL STRUCTURE Molecular Formula: Molecular Weight: 425.9 Chemical Name: (+,-) N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl) methylamino] propyl] tetrahydro-2-furancarboxamide hydrochloride CAS REGISTRY NUMBER 81403-68-1 DESCRIPTION Xatral (alfuzosin hydrochloride) is an orally active quinazoline derivative. Alfuzosin hydrochloride is a white to off white crystalline powder. It is freely soluble in water. N N CH 3 O CH 3 O NH 2 N CH 3 NH O O .HCl PRODUCT INFORMATION May 2013 Xatral and Xatral ER - alfuzosin hydrochloride xatral-xatral-er-ccdsv10-piv8-28may13 Page 2 The 2.5mg immediate release tablets are white, round and film-coated and each tablet contains 2.5mg of alfuzosin hydrochloride as the active ingredient and lactose, microcrystalline cellulose, povidone, sodium starch glycollate, magnesium stearate as excipients; Coating: hypromellose, macrogol 400 and titanium dioxide. The 5.0mg extended release tablets are a pale-yellow colour, round and film-coated and each tablet contains 5.0mg of alfuzosin hydrochloride as the active ingredient with microcrystalline Belgenin tamamını okuyun